RI
Repositioning IntelligenceResearch Intelligence · Not for Patient Care
All drugs

Drug profile

Levothyroxine (Synthroid)

Synthetic T4 thyroid hormone replacement that restores euthyroid state via thyroid hormone receptor activation.

Why this drug?

Levothyroxine is the gold-standard hormone replacement for hypothyroidism, with decades of clinical evidence, FDA-approved labeling, and guideline endorsement from endocrine societies.

Known risks

  • Overtreatment causing thyrotoxicosis
  • Cardiac arrhythmias if overdosed
  • Bone loss with supraphysiologic doses
  • Drug–food interactions (calcium, iron)

Evidence behind this

Confidence score98%
Signal strength: HighLevel 1 (guideline-endorsed standard of care)
Evidence grade
Approved

Normalization of TSH and symptom improvement; decades of clinical use.

Mechanism

Exogenous T4 restores normal thyroid hormone levels and metabolic homeostasis.

clinical trialfda labelmeta analysis

Authoritative sources

  • PubMed · 23846913

    ATA guidelines for hypothyroidism

    Jonklaas J et al. (2014)

    View
  • FDA · 021402

    Synthroid (levothyroxine) FDA label

    View

AI-generated summary

Generated March 15, 2026Last verified July 1, 2026

Levothyroxine is the established first-line therapy for hypothyroidism with FDA-approved labeling, ATA/AACE guideline endorsement, and extensive long-term safety data. This is primary-use evidence rather than repurposing, but represents gold-standard drug–disease pairing.

Source papers
  • Jonklaas J et al., Thyroid 2014

This summary is AI-assisted and human-reviewed. It does not constitute medical advice. Always consult authoritative sources and qualified professionals.